CYP2C19 and epilepsy: Table 4 and Figure 3 show the distribution of ADRs in patients with epilepsy treated with combination therapy, according to the CYP2C9 and CYP2C19 gene genotypes, their respective metabolic phenotypes, and the pharmacological regimen used.